Peter Schulam MD, PhD, presented “Surgical Management of Stone Disease” during the Jackson Hole Seminars on February 7, 2018 in Jackson Hole, Wyoming.

How to cite: Schulam, Peter. “Surgical Management of Stone Disease” February 7, 2018. Accessed Nov 2024. https://grandroundsinurology.com/Surgical-Management-of-Stone-Disease/

Surgical Management of Stone Disease

Summary:

Peter Schulam MD, PhD, discusses the 2016 American Urological Association (AUA)/ Endourology Society guidelines regarding observation of renal calculi, the treatment of ureteral and renal stones, urolithiasis during pregnancy, and the role of open surgery in stone disease. Specifically, he discusses medical expulsive therapy (MET), ureteroscopy, and shockwave lithotripsy (SWL). He finishes the talk with a brief summary on the use of each treatment, and their indications for various stone sizes and populations.

<script type="application/ld+json"><!-- [et_pb_line_break_holder] -->{<!-- [et_pb_line_break_holder] -->"@context": "http://schema.org",<!-- [et_pb_line_break_holder] -->"@type": "VideoObject",<!-- [et_pb_line_break_holder] -->"name": "Surgical Management of Stone Disease",<!-- [et_pb_line_break_holder] -->"description": "Peter Schulam MD, PhD, discusses the 2016 American Urological Association (AUA)/ Endourology Society guidelines regarding observation of renal calculi, the treatment of ureteral and renal stones, urolithiasis during pregnancy, and the role of open surgery in stone disease. Specifically, he discusses medical expulsive therapy (MET), ureteroscopy, and shockwave lithotripsy (SWL). ",<!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] -->"thumbnailUrl": "https://grandroundsinurology.com/wp-content/uploads/2018/06/Surgical-Management-of-Stone-Disease-copy-2.png",<!-- [et_pb_line_break_holder] -->"uploadDate": "2018-06-13",<!-- [et_pb_line_break_holder] -->"duration": "17:37",<!-- [et_pb_line_break_holder] -->"publisher": {<!-- [et_pb_line_break_holder] --> "@type": "Organization",<!-- [et_pb_line_break_holder] --> "name": "Grand Rounds in Urology",<!-- [et_pb_line_break_holder] -->"logo": {<!-- [et_pb_line_break_holder] --> "@type": "ImageObject",<!-- [et_pb_line_break_holder] -->"url": "https://grandroundsinurology.com/wp-content/uploads/2016/11/GRU_WebMedium-e1480706258120.jpg"<!-- [et_pb_line_break_holder] -->}<!-- [et_pb_line_break_holder] -->},<!-- [et_pb_line_break_holder] -->"embedUrl": "https://player.vimeo.com/video/274497527" <!-- [et_pb_line_break_holder] -->}<!-- [et_pb_line_break_holder] --></script>
Reveal Answer to Twitter Question

What is the best treatment for a symptomatic 1.5 cm proximal ureteral stone?

  • A. In situ SWL
  • B. Stent placement and SWL
  • C. Ureteroscopy and laser lithotripsy 
  • D. Percutaneous stone removal 

Answer explanation: The answer is Option C, ureteroscopy. Both shockwave and ureteroscopy are acceptable first-line therapies. But, ureteroscopy is oftentimes better for stones that are greater than 1 cm.

ABOUT THE AUTHOR

+ posts

Dr. Peter G. Schulam is Professor and Chair of the Department of Urology at Yale School of Medicine. He also serves as Chief of Urology at Yale New Haven Hospital and Chief Innovation and Transformation Officer of the Yale New Haven Health System. He is Faculty Director of the Tsai Center for Innovative Thinking at Yale, and Co-Founder of the Center for Biomedical Innovation and Technology.

Dr. Schulam graduated from the Medical Scientist Training Program at Baylor College of Medicine with an MD and a PhD in Immunology and completed his surgical and urologic training at Johns Hopkins Hospital in Baltimore, Maryland. Following a brief period at Baylor in Houston, he was recruited as the Chief of Minimally Invasive Surgery in the Department of Urology at UCLA. At UCLA, he developed laparoscopic and robotic surgery programs for prostate and kidney cancer. Dr. Schulam was also the Surgical Director of the Living Kidney Donor Program and performed over 1,200 laparoscopic living donor kidney procedures. At UCLA, he became the vice chair of the department and was actively involved in improving the patient experience throughout the hospital.

In January of 2012, he became the Chair of the Department of Urology at Yale. Dr. Schulam’s focus is to build a program that can offer every patient with any urologic condition state of the art diagnosis and treatment in an environment that is patient centered and is committed to listening and engaging the patient in their care.